The Deal Register
Database › Debt financing › Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS…

Debt financing

Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit…

Lane
Debt financing
Announced
16 Jul 2026
Province
Ontario
Industry
Unclassified
Status
Announced
What the filing says
Apotex Health Corp ("Apotex" or the "Company") (TSX: APTX ) today announced the successful completion of an amended and restated credit agreement ("Amended Credit Agreement"), establishing a financing framework aligned with the Company's evolution as a publicly traded, investment-grade-rated issuer.
Source

The terms are in the subscriber edition

This transaction carries the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe